Condition

Neuropathic Pain

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 66 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials66

Recruiting8

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic NeuralgiaNCT07712913 · 2026-06-18

Virtual Reality (VR) Self-Hypnosis SoftwareNCT06398847 · 2026-03-26

EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple SclerosisNCT07342777 · 2026-01-15

Thai PainPREDICT Validation StudyNCT07195045 · 2025-08-28

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMANCT05754190 · 2023-06-20

Neurosurgical Outcome NetworkNCT06724029 · 2022-12-05

Diabetic Neuropathy in Spinal Cord Stimulator PatientsNCT04687215 · 2022-01-27

Peripheral Nerve Block in Patients With Painful Diabetic PolyneuropathyNCT04699734 · 2020-09-08

OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNCT07221799 · 2026-09-01

NOT_YET_RECRUITING

Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple SclerosisNCT07786506 · 2026-08-10

NOT_YET_RECRUITING

Efficacy and Feasibility of BurstDR SCS in Painful Diabetic NeuropathyNCT07250828 · 2025-12-15

ENROLLING_BY_INVITATION

The Effect of Aromatherapy Foot Massage on Neuropathic Pain in Patients With Type2 DiabetesNCT07271160 · 2025-12-01

NOT_YET_RECRUITING

Use of taVNS for Painful Diabetic Neuropathy: 12-Week Randomized, Sham-Controlled TrialNCT06292962 · 2025-01-05

Neuropathic Pain and Type II Diabetic PatientsNCT06798181 · 2024-12-15

ACTIVE_NOT_RECRUITING

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyNCT06568042 · 2024-08-22

Chronic Pain in Post-Mastectomy Patients; The Difference Between Pectoral Nerve (PECS I-II) and Erector Spinal Plane (ESP) BlocksNCT06900842 · 2024-05-22

Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment for Chronic Painful Diabetic Peripheral NeuropathyNCT06171230 · 2024-03-01

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any GenesisNCT06072001 · 2023-11-02

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any GenesisNCT06071949 · 2023-11-02

Investigation of the Effects of Relaxation Exercises on Neuropathic Pain, Fatigue and Sleep QualityNCT06794918 · 2023-09-15

Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After MastectomyNCT06019325 · 2023-09-07

Neuropathic Pain Symptoms in ArthritisNCT05975281 · 2023-07-27

rTMS for the Treatment of Neuropathic Pain in Diabetic PatientsNCT05792072 · 2023-05-02

Algology in Oncology Osteopathic Support (ALGOS)NCT05726929 · 2023-01-11

Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical ManagementNCT05620225 · 2022-12-15

Effect of a Combined Exercise Program on Neuropathic Pain and Perceived Quality of Life in Type 2 DiabetesNCT05703152 · 2022-10-31

Pain Inflammation and Cannabis in HIVNCT05554146 · 2022-10-28

Pain, Inflammation, and Cannabis in HIVNCT04860089 · 2022-08-01

The Relationship of Neuropathic Pain With Incontinence, Disability and Life Quality in Multiple Sclerosis PatientsNCT05374811 · 2022-04-15

Evaluation of the Effect of Neuropathic Pain on Quality of Life in Rheumatoid Arthritis PatientsNCT04820426 · 2021-04-01

Reflexology in Diabetic Neuropathic Pain ManagementNCT04564131 · 2021-04-01

A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic PainNCT05624853 · 2020-05-12

Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)NCT05322889 · 2020-04-09

Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic PainNCT04075097 · 2019-07-31

The Effect of Lacosamide in Peripheral Neuropathic PainNCT03777956 · 2019-01-15

Symptom Management Efficacy Study to Reduce Distal Neuropathic PainNCT03855111 · 2019-01-14

Omnitram Safety and Efficacy in the Treatment of Diabetic NeuropathyNCT03664921 · 2018-11-15

Repetitive Transcranial Magnetic Stimulation as a Treatment for Pain in Parkinson's DiseaseNCT03350464 · 2018-04-05

Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple SclerosisNCT03219073 · 2018-02-01

Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast CancerNCT03022162 · 2017-12-01

Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:NCT03100474 · 2016-12-01

ACTIVE_NOT_RECRUITING

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)NCT01705626 · 2016-12-01

Nerveblocks for Persistent Pain After Breast Cancer SurgeryNCT02336529 · 2016-07-01

Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)NCT02673866 · 2016-02-01

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.NCT03047278 · 2015-11-01

Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO StudyNCT02555930 · 2014-12-01

Biomarkers of Neuropathic Pain in Women Treated for Breast CancerNCT02487524 · 2014-10-28

Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast SurgeryNCT02170415 · 2014-06-01

Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MSNCT01911377 · 2013-10-01

Donepezil Compared to Placebo in Patients With Chronic Neuropathic PainNCT01743976 · 2012-12-01

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological MechanismsNCT01523132 · 2011-11-01

Pain In Neuropathy StudyNCT02672059 · 2011-02-01

An Observational Post-Marketing Safety Registry of Sativex®NCT02073474 · 2011-02-01

Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.NCT03105765 · 2011-01-01

Pregabalin Trial In HIV Neuropathic PainNCT01145417 · 2010-07-01

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)NCT01138124 · 2010-03-01

Effects of Vaporized Marijuana on Neuropathic PainNCT01037088 · 2009-12-01

Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy PainNCT01089855 · 2009-12-01

Influence of Diabetes on Tramadol PharmacokineticsNCT02246712 · 2008-06-01

Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple SclerosisNCT00480181 · 2007-06-01

Common interventions

Leading sponsors

University of Manitoba3 Apurano Pharmaceuticals GmbH2 Jazz Pharmaceuticals2 Montefiore Medical Center2 University of Aarhus2 Ahi Evran University Education and Research Hospital1 Ataturk University1 Bilecik Seyh Edebali Universitesi1 Brainfarma Industria Química e Farmacêutica S/A1 Brown University1 Center for Medicinal Cannabis Research1 CENTOGENE GmbH Rostock1 Chulalongkorn University1 Comenius University1 Copenhagen University Hospital, Rigshospitalet1

Trial status mix

COMPLETED35

UNKNOWN9

RECRUITING8

TERMINATED6

NOT_YET_RECRUITING3

ACTIVE_NOT_RECRUITING2

WITHDRAWN2

ENROLLING_BY_INVITATION1

Phase mix

NA25

PHASE28

PHASE48

PHASE37

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.